Page 7 - Josephf Merola News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Josephf merola. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Josephf Merola Today - Breaking & Trending Today

Bristol Myers Squibb Data at the EADV 30th Anniversary Congress Highlight the Growing Body of Evidence on Deucravacitinib and Scientific Advancements for Patients with Serious Dermatologic Diseases

Bristol Myers Squibb Data at the EADV 30th Anniversary Congress Highlight the Growing Body of Evidence on Deucravacitinib and Scientific Advancements for Patients with Serious Dermatologic Diseases
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.

New South Wales , United States , April Armstrong , Joe Zhuo , Janin Edelkamp , Melinda Gooderham , Richard Warren , Jenny Xie , Mary Beth Harler , Richardb Warren , Farah Toublan , Neil Korman , Anjaneya Chimalakonda , Bristol Myers Squibb , Jashinj Wu , Josephf Merola , Kima Papp , Philip Mease , Thomas Alva Edison , Nina Goworek , Andrew Blauvelt , European Academy Of Dermatology , Bristol Myers Squibb Company , Health Economics , Fibrosis Development , Anniversary Congress ,

Dermavant Sciences: Dermavant Announces Tapinarof Data Presentations at the AAD VMX 2021

Dermavant Sciences: Dermavant Announces Tapinarof Data Presentations at the AAD VMX 2021
Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced that two abstracts from Dermavant s two pivotal Phase 3 trials for tapinarof for the treatment of psoriasis in adults, PSOARING 1 and PSOARING 2, will be presented during the upcoming American Academy of Dermatology Virtual Meeting Experience 2021 (AAD VMX 2021), on April 23-25, 2021.
Tapinarof is being developed as a novel, once-daily therapeutic aryl hydrocarbon receptor modulating agent (TAMA), cosmetically elegant, steroid-free topical cream for the treatment of plaque psoriasis and atopic dermatitis.
The following posters will be viewable on the conference platform for the entirety of the conference: ....

United States , April Armstrong , Paul Yamauchi , Laurence Watts , Mark Lebwohl , Stephenc Piscitelli , Philipm Brown , Laurak Ferris , Bruce Strober , Josephf Merola , Annam Tallman , Robert Bissonnette , Angela Salerno Robin , Neal Bhatia , Kostenloser Wertpapierhandel , Howard Sofen , Lawrencej Green , Davids Rubenstein , Andrew Blauvelt , Seemalr Desai , American Academy Of Dermatology Virtual Meeting , Roivant Sciences , Program For Tapinarof , Dermavant Sciences , Linkedin Dermavant Sciences , American Academy ,